期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

慢性肾脏病所致心血管疾病概述 被引量：7

Cardiovascular disease caused by chronic kidney disease
原文传递
导出
摘要 慢性肾脏病(CKD)是心血管疾病(CVD)的高危因素,CKD患者的CVD患病率很高,非常值得重视。本文将对CKD时的冠状动脉粥样硬化性心脏病、尿毒症心肌病、尿毒症心包炎、脑卒中及外周动脉病做一简介。 Chronic kidney disease （CKD）is a high risk factor of cardiovascular disease （CVD）. This paper introduces the coronary atherosclerotic heart disease, uremic myocardiopathy, uremic cardiopericarditis, stroke and peripheral arterial disease in patients with CKD.
作者 谌贻璞
机构地区 首都医科大学附属安贞医院肾内科
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2010年第2期108-110,共3页 Chinese Journal of Practical Internal Medicine
关键词 慢性肾脏病 心血管疾病 高危因素 chronic kidney disease cardiovascular disease high risk factor
分类号 R5 [医药卫生—内科学]
  • 相关文献

参考文献6

  • 1Perazella MA, Khan S. Increased mortality in chronic kidney disease :a call to action [ J ]. Am J Med Sci, 2006,331 ( 3 ) : 150 -153.
  • 2侯凡凡,马志刚,梅长林,戎殳,黄颂敏,刘先蓉,袁伟杰,郭云珊,王莉,何强,王秀玲,桑晓红,栗霄立.中国五省市自治区慢性肾脏病患者心血管疾病的患病率调查[J].中华医学杂志,2005,85(7):458-463. 被引量：182
  • 3McMahon LP, Parfrey PS. Cardiovascular aspects of chronic kidney disease. In : Brenner BM, ed. The Kid ney,Sth ed, Vol 2 [ J ]. Philadelphia: Saunders ,2007 : 1697 - 1727.
  • 4侯凡凡.慢性.肾脏病的心血管病变.见:王海燕主编.肾脏病学[M].3版.北京:人民卫生出版社,2008:1883-1896.
  • 5Aoki J, Ikari Y, Nakajima H ,et al. Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients [ J ]. Kidney Int,2005,67 ( 1 ) :333 - 340.
  • 6Alpert MA, Ravenscraft MD. Pericardial involvement in end-stage renal disease [ J ]. Am J Med Sci,2003,325 (4) :228 - 36.

二级参考文献16

  • 1侯凡凡.慢性肾脏病的心血管并发症[J].中华心血管病杂志,2004,32:16-16.
  • 2何长民 张训 见:何长民 张训主编.前言[A].见:何长民,张训主编.肾脏替代治疗学[C].上海:上海科学技术文献出版社,1999．2..
  • 3Locatelli F, Pozzoni P, Tentori F, et al. Epidemiology of cardiovascular risk in patients with chronic kidney disease. Nephrol Dial Transplant, 2003,18 Suppl 7:2-9.
  • 4Muntner P, He J, Hamm L, et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol, 2002,13:745-753.
  • 5Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol, 2003,41:47-55.
  • 6Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int, 1995,47:186-192.
  • 7Sarnak MJ, Levey AS, Schoolwerth AC,et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation, 2003,108:2154-2169.
  • 8Foley RN, Herzog CA, Collins AJ. Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 Study. Kidney Int, 2003,63:1462-1467.
  • 9Wong JS, Rort FK, Hulbert-Shearon TE, et al. Survival advantage in Asian American end-stage renal disease patients. Kidney Int, 1999,55:2515-2523.
  • 10Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998,32:s112-s119.

共引文献185

同被引文献49

  • 1郭华,马行一,王伟.心肾综合征的临床研究进展[J].心血管病学进展,2009,30(6):963-966. 被引量：11
  • 2侯凡凡,马志刚,梅长林,戎殳,黄颂敏,刘先蓉,袁伟杰,郭云珊,王莉,何强,王秀玲,桑晓红,栗霄立.中国五省市自治区慢性肾脏病患者心血管疾病的患病率调查[J].中华医学杂志,2005,85(7):458-463. 被引量：182
  • 3Melloni C, Mahaffey KW. Management of acute coronary syndromes in patients with renal dysfunction [ J ]. Curr Opin Cardio1,2008,23 (4) :320 -326.
  • 4Manjunath G ,Tighiouart H, Ibrahim H, et al. Level of kidney func- tion as a risk factor for atherosclemtic cardiovascular outcomes in the community[ Jl. J Am Coil Cardiol,2003,41 ( 1 ) :47 -55.
  • 5Attallah N,Yassine L, Fisher K, et al. Risk of bleeding and rest- enosis among chronic kidney disease patients undergoing percuta- neous coronary intervention [ J ]. Clin Nephrol, 2005,64 ( 6 ) : 412 -418.
  • 6Washam JB, Adams GL. Risks and benefits of antiplatelet therapy in uremic patients [ J ]. Adv Chronic Kidney Dis, 2008,15 ( 4 ) : 370 - 377.
  • 7Trovati M, Cavalot F. Optimization of hypolipidemic and antiplate- let treatment in the diabetic patient with renal disease [ J]. J Am Soc Nephrol,2004,15 ( Suppl 1 ) : S12 - 20.
  • 8Suranyi M, Chow JS. Review: anticoagulation for haemodialysis [ J ]. Nephrology (Carhon) ,2010,15 (4) :386 - 392.
  • 9Aronoff GR,Bennett WM, Berns JS, et al. Drug Prescribing in re- nal Failure. Dose Guidelines for Adults [ M ]. 5th ed. Philadelphia: American College of Physicians,2007:85 - 86.
  • 10Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guideline for the management of patients with unstable angina/ non-ST-elevation myocardial infarction : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines:Developed in collaboration with the American College of Emergency Physicians, Society of Academic Emergency Medicine, Society for Cardiovascular Angiography and Interven- tions,and Society of Thoracic Surgeons [ J ]. J Am Coll Cardiol, 2007,50 (7) : e1 - e157.

引证文献7

二级引证文献44

中国实用内科杂志
2010年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部